Minnesota Epilepsy Group

What Minnesota Epilepsy Group does

Minnesota Epilepsy Group, P.A. is a private professional association headquartered in Roseville, Minnesota, specializing in the diagnosis and treatment of adult and pediatric epilepsy and seizure disorders. Founded in 1991, the practice holds a Level 4 Epilepsy Center designation — the highest rating issued by the National Association of Epilepsy Centers — covering complex diagnostic monitoring (EEG, intracranial EEG, magnetoencephalography), medical management, epilepsy surgery (resective surgery, laser ablation), and neuromodulation device therapy (RNS, VNS, DBS). The practice also provides neuropsychology, psychology, and social work services, and maintains one of the largest pediatric epilepsy programs in the United States, treating thousands of children annually. Inpatient pediatric epilepsy monitoring is delivered through a co-location partnership with Children's Minnesota hospital system; adult care is anchored at the Roseville flagship plus newly opened satellite clinics in Fargo, ND and Hudson, WI.

The practice operates a sales-led/clinical-services business model: revenue is generated from outpatient evaluations, diagnostic procedures, surgical interventions, and device-management visits billed to insurance, Medicare, and Medicaid. Patient acquisition is driven primarily by physician referrals from community neurologists, self-referrals through the practice's website, and patient inquiry, with a maintained telemedicine channel extending reach across the Midwest. The practice participates in clinical trials for advanced neuromodulation devices and investigational medications, reinforcing the breadth of the service line beyond conventional pharmacological management for the refractory population that constitutes its core patient segment.

Operationally, the organization combines a large multidisciplinary clinical team — adult and pediatric epileptologists, neurosurgeons, neuropsychologists, NPs, PAs, EEG technologists, social workers, and dedicated Magnetic Source Imaging specialists — with established partnerships (Allina, Children's Minnesota) and a teaching/research posture through CME events and clinical research participation. The legal entity is a physician-owned professional association under Minnesota jurisdiction; ownership structure and any external investment are not publicly disclosed.

Name

Minnesota Epilepsy Group

Legal name

Minnesota Epilepsy Group, P.A.

Website

https://mnepilepsy.org

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

101–250 employees

Short description

Minnesota Epilepsy Group is a private Level 4 Epilepsy Center in Roseville, Minnesota, providing comprehensive adult and pediatric epilepsy diagnosis, surgery, and neuromodulation device therapy across the Midwest, with satellite clinics in Fargo, ND and Hudson, WI.

Ownership category

akta.pro rank

Product category

Neurology & Epilepsy Care

NAICS

Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Epilepsy & Seizure Disorders (HLAKAIAB)

akta.pro secondary industries

Outpatient Mental Health & Counseling Clinics (HLAFABAC), Pediatric Rehabilitation & Developmental Therapy Centers (PT/OT/SLP) (HLAFAJAL)

Keywords

• Epilepsy treatment services
• Neurology care services
• Seizure disorder treatment
• Pediatric epilepsy care
• Epilepsy diagnostics

Headquarters

HQ city

Minneapolis

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Healthcare Services: Minnesota Epilepsy Group generates revenue through providing comprehensive epilepsy healthcare services including outpatient evaluations, diagnostic testing (EEG, MEG), epilepsy surgery, neuromodulation device placement and programming, and ongoing patient care. Services are billed through insurance, Medicare, and Medicaid.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Minnesota Epilepsy Group is a Level 4 Epilepsy Center that diagnoses and treats adult and pediatric epilepsy and seizure disorders across the continuum of care. Its offerings include outpatient evaluations, EEG and MEG diagnostics, intracranial EEG, neuropsychological assessment, epilepsy surgery (resective surgery and laser ablation), neuromodulation device placement and programming (RNS, VNS, DBS), and continuous clinical-trial participation. It delivers these services through its Roseville, MN headquarters, satellite clinics in Fargo, ND and Hudson, WI, inpatient services at Children's Minnesota, and telemedicine visits.

Product overview

Minnesota Epilepsy Group operates as a Level 4 Epilepsy Center—the highest designation from the National Association of Epilepsy Centers—offering comprehensive epilepsy care as a unified medical practice. The practice provides the full continuum of seizure disorder services including medical management, surgical interventions (epilepsy surgery, laser ablation, intracranial EEG), neurostimulation devices (RNS, VNS, DBS), advanced diagnostic imaging (magnetoencephalography), neuropsychology, and pediatric epilepsy care. The practice is the largest and most comprehensive adult and pediatric epilepsy program in the Midwest, with satellite clinics in Hudson, WI and Fargo, ND extending access beyond the Roseville, MN main location.

Differentiator

Problem solved

Functional benefit

Products and services

• Level 4 Epilepsy Center Services Comprehensive diagnostic and treatment services for epilepsy, operating under a Level 4 Epilepsy Center designation — the highest rating by the National Association of Epilepsy Centers. Includes epilepsy monitoring, medical management, and surgical interventions for adult and pediatric patients.
• Epilepsy Surgery Surgical treatment options for patients with medically refractory epilepsy, including resective surgery, laser ablation, and intracranial EEG monitoring. Intended for adult and pediatric patients who do not respond to medication.
• Intracranial EEG Advanced diagnostic monitoring involving electrode placement inside the skull to precisely locate seizure foci for surgical planning. Used for epilepsy surgery candidates whose non-invasive testing has not localized seizure onset.
• Magnetoencephalography (MEG) Non-invasive neuroimaging technique that measures magnetic fields produced by brain electrical activity to localize seizure onset zones and map brain function. Used for epilepsy presurgical evaluation and functional brain mapping.
• Laser Ablation for Epilepsy Minimally invasive surgical procedure using laser technology to precisely ablate seizure-causing brain tissue. Intended for selected surgical epilepsy candidates as an alternative to open resective surgery.
• Neuropsychology Services Comprehensive neuropsychological testing and assessment services to evaluate cognitive function and support epilepsy diagnosis and treatment planning.
• Outpatient Evaluations Ambulatory evaluation services for epilepsy diagnosis and ongoing treatment management, offered to adult and pediatric patients at the practice's clinic locations.
• Pediatric Epilepsy Program One of the largest pediatric epilepsy programs in the nation, providing specialized care for children with seizures including diagnostic services, medical management, and surgical interventions. The pediatric team sees thousands of children annually.
• Responsive Neurostimulation (RNS) An FDA-approved closed-loop brain stimulation system that monitors brain electrical activity, detects seizures, and delivers electrical stimulation to stop seizure activity. Approved for adults 18 years or older with refractory focal epilepsy. Offered as part of the practice's neuromodulation device therapy options.
• Vagus Nerve Stimulator (VNS) FDA-approved device therapy involving a battery placed under the skin on the left chest connected to the vagus nerve in the neck, delivering electrical stimulation to reduce seizure frequency. Provided to qualifying epilepsy patients as part of the practice's neuromodulation services.
• Deep Brain Stimulator (DBS) Surgical device with probes placed deep in the brain (anterior nucleus of the thalamus) programmed to deliver electrical stimulation to reduce seizure activity. Offered as part of the practice's neuromodulation services for selected epilepsy patients.
• TeleMedicine Visits Virtual healthcare appointments allowing patients to receive epilepsy care remotely via video consultations. Expanded during the COVID-19 pandemic and offered alongside in-office appointments.
• Educational Award Program Financial educational award program offering $2,500 to four patients with epilepsy seeking higher education or training.

Quantifiable outcome

• RNS clinical trial patients reported average 40% reduction in seizures after 3 months, 50% reduction at 2 years, and nearly 65% reduction by 6th year of device activation.
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• AllinacoreStrategic or Co-development PartnerAllina is listed as a partner organization. Minnesota Epilepsy Group appears to work collaboratively with Allina Health System for patient care services. Their logo appears in the footer of the website alongside other partner organizations.
• Children's MinnesotacoreStrategic or Co-development PartnerChildren's Minnesota is a key partner where pediatric epilepsy monitoring services are provided. Services relocated from St. Paul to Minneapolis hospital location. Minnesota Epilepsy Group's pediatric epileptologists provide care at Children's Minnesota facilities.

Scale indicators3 records

Recent moves9 records

Expansion highlights5 records

Others

• NeuroPace: Manufacturer of the RNS System, a core neuromodulation device deployed by Minnesota Epilepsy Group. Adjacent ecosystem participant; key technology vendor and clinical-trial partner.
• LivaNova: Manufacturer of the Vagus Nerve Stimulation (VNS) system, one of the neuromodulation therapies offered at the practice. Ecosystem participant and device partner, not a direct competitor.
• Allina Health: Stated partner health system of Minnesota Epilepsy Group (logo appears in site footer). Large regional health system providing referral infrastructure and patient access across the Twin Cities.

Broad incumbents

• Cleveland Clinic: Houses one of the largest NAEC Level 4 epilepsy centers in the U.S., with full surgical, neuromodulation, and MEG capability. Comparable in service breadth to Minnesota Epilepsy Group and competes nationally for complex epilepsy referrals.
• Mayo Clinic: Rochester, MN-based academic medical center with a comprehensive Level 4 epilepsy program and deep research infrastructure. Operates within the same Minnesota catchment area and is the most consequential competitor for complex adult and pediatric epilepsy referrals in the region.
• Emory University Epilepsy Center: NAEC Level 4 academic epilepsy program with comprehensive adult/pediatric services including surgery and device therapy. Comparable in clinical depth and serves as a benchmark for outcome-driven academic epilepsy care.

Regional players

• UW Health (University of Wisconsin) Epilepsy Program: Level 4 epilepsy program serving Wisconsin with surgical and device-based therapy. Direct geographic overlap with Minnesota Epilepsy Group's Hudson, WI satellite; competes for the same referral base.
• RUSH University Medical Center Epilepsy Center: Chicago-based NAEC Level 4 program offering adult and pediatric epilepsy services including surgery and neuromodulation. Comparable in clinical scope; draws referrals from overlapping Midwest populations.
• Michigan Medicine (University of Michigan Comprehensive Epilepsy Center): NAEC Level 4 academic epilepsy program serving the Midwest with similar adult/pediatric scope. Competes for tertiary referrals in adjacent Midwest geographies and is a regional comparator in terms of scale and capability.

Direct peers

• Children's Minnesota: Hospital partner that hosts Minnesota Epilepsy Group's pediatric epilepsy monitoring unit. Functions as a co-located pediatric neurology partner and is one of the practice's most important referral and inpatient relationships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/mnepilepsy
• LinkedInlinkedin.com/company/mnepilepsy
• Xx.com/mnepilepsy

Revenue estimate

Valuation estimate

Number of profiles

Profiles35 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Minnesota Epilepsy Group